Search / Trial NCT06228196

Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Jan 18, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Bppv Residual Dizziness Vertigo Neuroimaging Epidemic

ClinConnect Summary

This clinical trial is studying a condition called benign paroxysmal positional vertigo (BPPV), which causes episodes of dizziness when a person changes their head position. The goal is to understand how BPPV affects patients' physical health, mental well-being, and blood tests. Researchers also want to create a database that uses advanced brain imaging techniques to identify patients who might still experience dizziness after treatment. This work aims to improve how BPPV is diagnosed and managed in China.

To participate in this study, individuals must have a confirmed diagnosis of BPPV, or they can be healthy volunteers who have never had BPPV. However, people with certain serious medical conditions, such as brain tumors or mental health disorders, cannot join. Those who take part can expect to undergo assessments that will help researchers learn more about BPPV and how to treat it effectively. Overall, this study is important for finding better ways to help people who struggle with dizziness related to BPPV.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Confirmed diagnosis of BPPV/Healthy subjects who have not had BPPV
  • Exclusion Criteria:
  • History of organic diseases in central nervous system and mental disorder, such as tumors, infections, depressive disorder, schizophrenia, etc. Claustrophobic

Trial Officials

Yuan Wang, M.D.

Principal Investigator

First Affiliated Hospital of Xian Jiaotong University

About First Affiliated Hospital Xi'an Jiaotong University

The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.

Locations

Xi'an, Shaanxi, China

Xi'an, Harbin, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0